The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of ZW25, a bispecific anti-HER2 antibody, in patients with advanced HER2-expressing cancers.
 
Diana Felice Hausman
Employment - Oncothyreon; Zymeworks
Leadership - Oncothyreon; Zymeworks
Stock and Other Ownership Interests - Oncothyreon; Zymeworks
 
Erika Paige Hamilton
No Relationships to Disclose
 
Muralidhar Beeram
No Relationships to Disclose
 
Jamuna Thimmarayappa
Employment - Zymeworks
Stock and Other Ownership Interests - Zymeworks
 
Gordon Ng
Employment - Zymeworks
Leadership - Zymeworks
Stock and Other Ownership Interests - Zymeworks
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche
Consulting or Advisory Role - Celgene; Genentech; Inflection Biosciences; Novartis; Roche
Research Funding - Aileron Therapeutics; AstraZeneca; Bayer; Calithera Biosciences; CytomX Therapeutics; Debiopharm Group; Genentech; Novartis; PUMA Biotechnology; Taiho Pharmaceutical; Verastem